|
KMID : 1007020050030010062
|
|
Korean Soceity of Osteroporosis
2005 Volume.3 No. 1 p.62 ~ p.66
|
|
|
Effects of Oral Pamidronate in Treatment of Primary Osteoporosis
|
|
Koh Bo-Ram
Kim Hyoung-Il
Kim Yeon-Kyeong
Ahn Sang-Mi
Song Kyoung-Eun
Jung Sun-Hye
Kim Hae-Jin
Kim Dae-Jung
Lee Kwan-Woo
Chung Yoon-Sok
|
|
|
Abstract
|
|
|
Objectives: Bisphosphonates are well-known agents for treatment of osteoporosis. Oral pamidronate treatment for osteoporosis were studied in Caucasian, but not in Korean. Effects of oral pamidronate were studied in Korean primary osteoporosis patients.
Methods: Twenty four(11 men and 13 women) primary osteoporosis patients were treated with 100mg of daily pamidronate(panorin, Hanlim Co., Korea) for mean duration of 13.5±1.9months. Serum alkaline phosphatase, urine calcium/ creatinine ratio, bone mineral densities of spine(L1-4) and femur(neck, trochanter, ward, and total) were followed-up.
Results: Serum alkaline phsophatase decreased from 95.3±28.0 to 69.4±23.1IU/L(P＜0.01). Urine calcium/creatinine ratio decreased from 0.132±0.076 to 0.083±0.052(P＜0.05). Bone mineral density of spine increased from 0.788±0.137 to 0.841±0.144g/cm2(P＜0.01). Bone mineral density of total proximal femur increased from 0.819±0.099 to 0.833±0.098g/cm2(P＜0.05).
Conclusion: Oral pamidronate treatment for 1 year was effective in increasing bone mineral density and decreasing biochemical bone turnover rate. Further study of prospective randomized double blind trial will be needed.
|
|
|
KEYWORD
|
|
|
Oral Pamidronate, Osteoporosis, Bone mineral density
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|